Hsiao et al. provided detailed evidence that the analgesic effect of oral eicosapentaenoic acid (EPA) in fibromyalgia model mice was associated with suppressed astrocyte activation and the reduced release of proinflammatory signaling factors, including HMGB1 and S100B. Here, HMGB1 is linked to fibromyalgia.